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Background: Decisions to scale up population health interventions from small projects to wider state or national
implementation is fundamental to maximising population-wide health improvements. The objectives of this study
were to examine: i) how decisions to scale up interventions are currently made in practice; ii) the role that evidence
plays in informing decisions to scale up interventions; and iii) the role policy makers, practitioners, and researchers
play in this process.
Methods: Interviews with an expert panel of senior Australian and international public health policy-makers (n = 7),
practitioners (n = 7), and researchers (n = 7) were conducted in May 2013 with a participation rate of 84%.
Results: Scaling up decisions were generally made through iterative processes and led by policy makers and/or
practitioners, but ultimately approved by political leaders and/or senior executives of funding agencies. Research
evidence formed a component of the overall set of information used in decision-making, but its contribution was
limited by the paucity of relevant intervention effectiveness research, and data on costs and cost effectiveness.
Policy makers, practitioners/service managers, and researchers had different, but complementary roles to play in the
process of scaling up interventions.
Conclusions: This analysis articulates the processes of how decisions to scale up interventions are made, the roles
of evidence, and contribution of different professional groups. More intervention research that includes data on the
effectiveness, reach, and costs of operating at scale and key service delivery issues (including acceptability and fit of
interventions and delivery models) should be sought as this has the potential to substantially advance the
relevance and ultimately usability of research evidence for scaling up population health action.
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To maximise the impact of public health research, inter-
ventions found to be effective in improving health need to
be scaled up and delivered on a population-wide basis. The
transfer of new knowledge from public health research into
practice, however, continues to be sub-optimal [1]. On
average, it takes over 6 years for research evidence to reach
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Both the failure of effective public health initiatives to
influence public health practice and the lag between
evidence generation and implementation represent
considerable impediments to population health im-
provement as it denies or delays community access to
effective services [3-5].
Scaling up is the process by which health interventions
shown to be efficacious on a small scale and/or under
controlled conditions are expanded under real world
conditions into broader policy or practice [6,7]. Under-
standing how policy makers and practitioners make de-
cisions about whether to scale up interventions and thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Milat et al. Health Research Policy and Systems 2014, 12:18 Page 2 of 11
http://www.health-policy-systems.com/content/12/1/18role of evidence in these decisions, may facilitate more
complete and timely translation of research into practice.
This issue of how best to scale up health interventions
has been receiving some recent attention, particularly in
the global health literature [6,8-13] and through case
studies [8,10,12,14,15]. However, there are few studies in
high-income countries.
The concept of scaling up is different from routine
adoption as it involves an explicit intent to expand the
reach of an intervention to new settings or target groups.
Norton and Mittman [11] examined key barriers and fa-
cilitators to scaling up of 10 disease prevention programs
in the United States using interviews with program repre-
sentatives. Key barriers to scaling up included reluctance
by implementing organisations to fully integrate pro-
grams into routine service delivery on top of existing
workloads and a lack of resources to implement pro-
grams with fidelity or at all in “real-world” settings, par-
ticularly when the efficacy trials generating the evidence
had been expensive. Key success factors included sus-
tained involvement of highly committed individuals and
the development of scaled up programs in community
settings, rather than more traditional researcher-initiated
and managed programs.
Similarly, a literature review and two-stage Delphi
process with 14 senior Australian population health policy
makers and researchers [6,9] concluded that scaling up
can be aided by producing information on effectiveness,
reach, and adoption, human, technical, and organisational
resources, costs, intervention delivery arrangements, con-
textual factors, and applying appropriate evaluation ap-
proaches. This study concluded that if these “scalability
considerations” are addressed in the funding, design, and
reporting of intervention research, it could advance the
quality and usability of research for decision makers, and
by so doing, improve uptake and expansion of promising
programs into practice [6].
Though these recent studies, made up primarily of case
studies, literature reviews and interviews with policy
makers and practitioners [6,11,12,16] describe principles
of scaling up of health interventions, none have specific-
ally examined how scaling up decision processes actually
occur in the real world using respondents actively in-
volved in population health scaling up decision processes.
Furthermore, there remains an absence of a comprehen-
sive and systematic description of the respective roles
that policy makers, practitioners, and researchers play in
these processes. The empirical study of these factors is
important on a number of levels. Firstly, the failure to ac-
count for differing decision-making processes and incen-
tives for researchers, policymakers, and practitioners has
been purported as a major contributor to the lack of con-
sistent and systematic transfer of research evidence into
broader policy and practice [16,17]. Such research alsoprovides a more pragmatic way of understanding how re-
search can be used, grounded in real policy making pro-
cesses, rather than idealised accounts of how this could
occur.
In light of these gaps in our knowledge, the objectives
of the current study were to examine:
i) how decisions to scale up population health
interventions in high-income country contexts are
made in practice;
ii) the role that research evidence plays in informing
decisions to scale up promising interventions; and
iii) the roles policy makers, practitioners, and
researchers play in the process of scaling up
population health action.
Methods
The selection of experts
Purposeful sampling techniques were used as expert opin-
ions were sought from senior policy makers, practitioners,
and researchers [18]. Experts invited to participate in the
study comprised current and former senior government
and non-government policy makers, selected by the study
investigators for their extensive experience in commis-
sioning and or implementing large scale population health
programs at state, national, or international levels; senior
practitioners/service managers selected for their extensive
experience in the on-the-ground implementation of local
population health programs; and senior researchers,
mostly Associate Professor or above, selected for their ex-
tensive experience as chief investigators of applied and
intervention research. Policy makers were employed by a
mix of state-wide, national, and international policy mak-
ing agencies. Where experts were employed as policy
makers or practitioner/service managers and simultan-
eously held academic appointments, respondents were
categorised as either policy makers or practitioners. The
sample of experts were selected mainly from Australia,
but also from Asia, United Kingdom, and the United
States. Using similar health promotion studies seeking ex-
pert opinion as a benchmark, the current study aimed to
recruit approximately 20 respondents [19].
Interviews
Interviews were conducted by a research assistant with
over 10 years’ experience in the conduct of qualitative
methods and included a mix of open and closed ques-
tions to assess how these decision makers had made deci-
sions to scale up interventions in practice, how evidence
had informed their decisions and the respective roles pol-
icy makers, practitioners, and researchers had played in
these scaling up processes. The interview questions ad-
dressed the aforementioned gaps in the knowledge base
identified in previous research [6]. All interviews were
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corder and later transcribed. For international respondents
the interview rounds used the same questions, but were
completed as self-administered surveys. The interview
questions used in the study are shown below.
Interview/survey questions
1. How many years’ experience do you have in the
development, implementation, and or evaluation of
population health interventions? [Years]
2. What is your current role? [Policy maker;
Researcher; Both policy maker and researcher;
Practitioner/Service Manager; Consultant; Other]
3. Have you ever been involved in decision processes
to scale up population health interventions into
broader policy or practice?
(Prompt, if required: By scaling up we mean taking a
health intervention shown to be efficacious on a small
scale and or under controlled conditions and
expanding it under real world conditions into broader
policy or practice. Decision processes are processes by
which decision makers identify information, evaluate
alternatives, and make decisions on courses of action.)
[Yes/No]
4. In the past five years, how many times have you been
involved in decision processes to scale up population
health interventions? [Times]
Now, thinking specifically about the last time you
were involved in a decision process to scale up a
population health intervention.
4a.Could you briefly describe the intervention?
4b.What formal processes, if any, were undertaken
to inform decisions to scale up the intervention
(or not)? (Prompts if required: stakeholder
consultation, expert consultation, Advisory
Group, meetings of Ministers, etc.)
4c.What role did you personally have in the
decision processes? (Prompts if required: Policy
maker, advocate, expert, advisor, etc.)
4d.How or by whom was the final decision to scale
up the intervention (or not) made? (Prompts if
required: political process, policy process, an
individual such as a Minister or senior
bureaucrat, by a Government/s, etc.)
4e.What (if any) influence did research evidence
have on the decision processes?
4f. If research evidence did influence the decision
processes, what type of research was used and
how was it applied? (Prompt if necessary:
descriptive epidemiology, determinants research,
formative research, measurement research,
intervention research, economic evaluation, etc.)4g.What factors and information sources, if any,
enabled decision-making about whether to scale
up the intervention or not?
4h.What factors were barriers to decision-making
about whether to scale up the intervention or
not?
4i. What were the final outcomes of these decision
processes? (Prompt if necessary: intervention was
scaled up, intervention abandoned, etc.)
4j. Was this process typical? If not, can you describe
how it differed from other processes (if any) you
have been involved in previously.5. From your experience, what roles do policy makers
and researchers play in process of scaling up
population health interventions? (Prompts in
required: how do they differ and why?)
6. From your experience, what are the most powerful
influences on decisions to scale up population health
interventions? In your opinion, which should be the
most important influences on decisions to scale up
population health interventions?
Now, thinking about operationalizing decisions to
scale up population health interventions into
broader policy and practice.
7. Have you ever been responsible for implementing a
process of scaling up a population health
intervention into broader policy or practice?
(Prompt, if required: by scaling up we mean taking a
health intervention shown to be efficacious on a
small scale and/or under controlled conditions and
expanding it under real world conditions into
broader policy or practice.) [Yes/No]
8. From your experience, what do you think are the
key barriers to effectively scaling up population
health interventions into broader policy and
practice?
9. From your experience, what do you think are the
key success factors in scaling up population health
interventions into broader policy and practice?
Data analysis
The lead author and research assistant collated responses
to quantitative survey items. A two-stage qualitative ‘the-
matic analysis’ method [20] was used to interpret re-
sponses to open-ended questions. Thematic analysis is a
widely used method for identifying, analysing, and
reporting patterns (themes) within data [21]. In this
study, thematic analysis involved the lead author and re-
search assistant independently assessing transcribed re-
sponses to identify broad coding themes for each
question. These independently generated draft coding
frames were tabled and discussed and final agreement on
the code frame was reached. This process was followed
by a final joint thematic analysis of the data.
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Results
Response rates and respondent characteristics
Of the 25 invited experts, 21 agreed to participate (84%
response rate), with 7 of 8 policy makers, 7 of 7 practi-
tioners/service managers, and 7 of 10 researchers
approached agreeing to participate. Policy-makers (n =
7) possessed a mix of senior policy experience at the
state, national, and international levels, and had a mean
of 18 years’ experience in commissioning and/or con-
ducting major intervention research trials and oversee-
ing implementation of large-scale population health
programs. Practitioners/service managers possessed ex-
tensive service development experience at local and re-
gional levels and had a mean of 17.4 years’ experience
in overseeing intervention research trials and expand-
ing the implementation of prevention programs. The
sample of researchers (n = 7) was a mix of Australian
and international University based experts in public
health, health services, and health promotion research
with a mean of 22.1 years of experience. Four of the 21
respondents held senior public health or academic po-
sitions in Asia, Europe, or the United States.
Involvement in the decision-making processes and
implementation of scaling up processes
All of the policy makers and practitioners and 6 of the 7
researchers interviewed had been or were currently in-
volved in decisions about whether to scale up population
health interventions into policy and practice.
Respondents were also asked how many times in the
past 5 years they had been involved in decision processes
to scale up population health interventions. Researchers
most frequently reported involvement in between 1 and
6 cases and policy makers and practitioners most fre-
quently reported involvement in 10 or more and 6 or
more cases of decision processes, respectively.
All of the policy makers and practitioners interviewed
had been responsible for implementing scaled-up inter-
ventions into policy and practice, while 2 of 7 researchers
had experienced such a responsibility.
The type of interventions scaled up
Respondents were asked to describe the most recent
intervention for which they were involved in scaling up
related decision processes (Table 1). The 20 interven-
tions described by respondents included lifestyle behav-
iour change, organisational change, brief intervention
counselling, social marketing, and sponsorship. They ad-
dressed issues such as healthy eating, physical activitypromotion, chronic disease prevention and management,
diabetes prevention, and alcohol and tobacco control. The
scaled-up interventions were implemented in a variety of
settings, focusing on either children or adults. Interventions
were implemented mainly in Australia, but also in the pa-
cific region, United States, and South America.
In-depth interviews
Scaling up decision processes
Respondents across professions reported that formal
scaling up processes were generally iterative, and were
run by policy makers and or practitioners: ‘It was an it-
erative process. We got technical expert advice from the
market about the do-ability …which was very important
because it was all very well coming up with the idea but
without the practical, this is how much it will cost and
yes it’s available, you can do it or you can’t do it, it was
all kind of moot… It was also important for our minister
to be able to say we had that consultation and we had
that credibility with the public health community’ (PM).
Policy makers described the process of constructing a
case for action for the consideration and endorsement of
political leaders and senior executives in the form of par-
liamentary, ministerial, and executive briefings. Policy
makers rarely made decisions in isolation and without
first seeking senior endorsement of proposed approaches
and associated budgets from senior delegates. One se-
nior policy maker described the process as follows: ‘The
Minister is actually making a decision to fund a pro-
gram. It’s not a conscious decision that they are scaling
up… from research evidence into a state-wide program…
The decision is about what advice policy makers give to
the Minister and based on this advice the Minister makes
a decision about whether to fund the program.’ (PM);
and ‘…ultimately we had to take it to our minister as a
package proposal’ (PM).
It was observed that decisions to scale up interventions
were almost always subject to processes of either internal
and/or external consultation through organizations and/
or stakeholder networks, using advisory committees,
working parties, expert advice, and often involving re-
searchers either directly or indirectly: ‘We formed a clin-
ical advisory group with clinicians to formulate the model
of care. Then we rolled it out. We then formed partner-
ships with each of the, what we call, clusters, groups of
community health services. We formed partnerships with
their executives where they gave us local advice’ (P/SM).
Researchers agreed that while they might formulate
recommendations, ultimate decisions to scale up inter-
ventions were generally made by policymakers and prac-
titioners within government agencies, over which they
had little control. Researchers reported that they collated
and provided evidence to others in a number of forms
and forums, including systematic reviews, intervention
Table 1 The type of interventions that were scaled up into broader policy and practice





1. Healthy eating Policy & practice change in Canteens Schools Children State-wide Australia
2. Physical activity Brief intervention Primary care Adults Local Australia
3. Physical activity Exercise classes Community Adults National Brazil
4. Healthy eating & physical
activity
Policy & practice change and provider training Childcare Children Local Australia
5. Healthy eating & physical
activity
Lifestyle modification program Community Adults State-wide Australia
6. Healthy eating & physical
activity
Policy & practice change and curriculum
support
Schools Children State-wide Australia
7. Healthy eating & physical
activity
Policy & practice change and provider training Childcare Children Local Australia
8. Diabetes Lifestyle modification program Primary Health Care Adults Local Australia
9. Healthy eating and
physical activity
Whole of school policy & practice change Schools Children National Fiji
10. Healthy weight Lifestyle modification program Community Children State-wide Australia
11. Chronic disease
management
Lifestyle modification program Community Adults State-wide Australia
12. Chronic disease risk
factors
Brief interventions and referral Community health
services
Adults Local Australia
13. Chronic disease risk
factors
Brief interventions General practice Adults National Australia
14. Chronic disease risk
factors
Brief intervention and referral Community health
services
Adults Local Australia
15. Chronic disease risk
factors





16. Diabetes prevention Lifestyle modification program Health services Adults National USA
17. Diabetes prevention Lifestyle modification program Primary health
services
Adults Local Australia
18. Tobacco cessation Mass media campaign Community Adults & young
people
State-wide Australia
19. Binge drinking Government sponsorship of sport and social
marketing campaign
Community Young people National Australia
20. Falls prevention Website & group based exercise/education
program
Community Adults State-wide Australia
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ways sure how that evidence was then used by others to
inform the decisions that were made about scaling up
the intervention: ‘I was consulted around interpreting
the findings and being asked to give my opinion about
recommendations for the future, but how those were con-
sidered with the processes that were followed to make the
final decision internally I don’t know’ (R).
Some researchers noted that their role in decision-
making processes went beyond providing evidence, to
one of advocating for particular approaches: ‘I was asked
to sit on the steering committee for this play space initia-
tive and then it was through that that I put forward or
really advocated for consideration of our evidence-based
intervention as part of the fleet of programs, chronicdisease prevention and management programs that would
be scaled up and delivered’ (R).
There was consistency in the view that the context for
decisions about whether to scale up interventions is
highly political, rapidly changing, and influenced by a
variety of factors, inputs, and relationships, including in-
dividuals’ values, skills, and experience. Respondents
across occupational groups noted that the most powerful
influences over scaling up processes were political and
resource related: as one policy maker put it: ‘Politicians.
One stroke of the pen, done’ (PM); and as a practitioner/
service manager put it: ‘…obviously you need to have suf-
ficient resources to enable it to happen, or at least have
commitment that the resources will be available or can
be attainable’ (P/SM).
Milat et al. Health Research Policy and Systems 2014, 12:18 Page 6 of 11
http://www.health-policy-systems.com/content/12/1/18The role of evidence in scaling up processes
Most decision-making processes associated with scaling
population health interventions involved consideration
of a variety of information sources, not just research evi-
dence. Many respondents across occupation groupings
observed that while research evidence was important,
other contextual information or political influences also
appeared to have a strong influence on the final out-
come of decision processes. For example, alignment with
government priorities and political imperatives, funding
availability, leadership support, and support from stake-
holders were thought to be particularly important influ-
ences by policy makers. Where research evidence was
available, decisions were based on a body of evidence ra-
ther than a single study: ‘The government doesn’t just
make decisions on the basis of one research project… but
about the overall body of evidence… And so I think in
terms of research evidence in general, I think it had quite
a strong influence but it’s not just the only factor, so it’s a
kind of necessary but insufficient condition’ (R).
A key theme identified by a number of policy makers
acknowledged that research evidence was the starting
point, but that: ‘…I knew that I had to take into account
the policy context, the relationships we had politically
with Ministers and the relationship we had between dif-
ferent sectors’ (PM).
Conversely, some policy makers suggested that from
time to time decisions had been made without solid evi-
dence, particularly where potential gains to the health of
population are great: ‘Plenty of critics were happy to say
“well it’s never been done before, how do you know it will
work?” That’s the reality of any large scale population-
based intervention. Someone has to do it first. Someone
had to legislate to make us wear seatbelts first’ (PM).
The types of research evidence reported as having been
used in decision processes varied greatly, and comprised
epidemiological data, intervention research, systematic
reviews, controlled trials, and local quasi-experimental
pilot studies. Policy makers and practitioners noted that
epidemiological evidence was used to determine the na-
ture and scope of a problem and for surveillance pur-
poses: ‘Epidemiology or prevalence data provided a map
or primary rationale for working in the setting’ (P/SM).
Respondents frequently reported the use of evidence
from systematic reviews where these were available to
build a case for scaling up the intervention: ‘We also
used the evidence available from systematic reviews to
argue that if the intervention was delivered, a risk reduc-
tion outcome could be achieved’ (P/SM).
Policy makers and practitioners identified a paucity of
intervention research in the literature to inform scaling
up efforts, as one policy maker put it: ‘The evidence pro-
vided us with clues to what might be appropriate to in-
clude… so the sorts of things about how many call backswere required…who should we be targeting, so there was
no single research study but it was elements of other sorts
of bits and pieces of programs that we needed to make a
judgment call on’ (PM).
When intervention research was available, this evi-
dence alone rarely provided policy makers with all of the
information they needed to scale up interventions: ‘So
few research studies provide the really nuts and bolts in-
formation that a policy maker would require’ (PM).
Research evidence was almost always adapted to con-
text and situation. ‘Off the shelf ’ interventions were gen-
erally not seen as appropriate by policy makers and
practitioners unless they had been developed to suit the
local context. Local evidence had a higher value because
it was considered more likely to successfully translate
into practice. Local evidence of efficacy or evidence from
local pilots or replication studies was thought to be par-
ticularly persuasive: ‘We used the local evidence we had
gathered to show that the intervention could be delivered
at no cost to service delivery and was acceptable to the
service providers’ (P/SM).
A number of policy makers and practitioners observed
that where direct evidence of effectiveness was not avail-
able, parallel evidence from other settings or health is-
sues or countries was sometimes used: ‘Then we also
looked at, as I mentioned, other health topics, like so if
we looked for research where there had been some up
scaling, whether or not it was specific to our health topic
or not, but specific to the setting…’ (P/SM). Both policy
makers and practitioners spoke of drawing on the evi-
dence in relation to the principles of successful interven-
tions or best practice population health approaches and
theories, in cases where sufficient evidence was not
available.
Grey literature (including technical reports) was
thought by policy makers and practitioners to be a par-
ticularly useful source of evidence as it often provided
more ‘how to’ information than peer reviewed papers, al-
though it could be difficult to access. Where this infor-
mation was not available, advice and information was
often directly sought from people who had implemented
similar programs: ‘…a lot of the research is grey when it
comes from other departments and closely held so that
always makes it difficult. There’s a lot of searching out
the project managers, the project workers and talking to
them personally…what their perspectives were, how they
actually make things happen on the ground and then
what are the process outcomes…’ (PM).
Respondents across occupational groupings in the sam-
ple, but particularly policy makers, stated that evidence of
implementation costs and cost effectiveness had been
rarely available to them from the research literature, and
yet were needed to inform scaling up processes: ‘I think
one of the barriers was the lack of costing information.
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fectiveness data on $1 spent here is going to give you $5 in
return. We had evidence that it was effective, but we
didn’t have evidence that it was cost effective’ (PM).
Many respondents across occupational groupings in
the study sample observed that the value and import-
ance of considering information in relation to the organ-
isational fit of an intervention, and the acceptability and
feasibility of the intervention to individuals and delivery
agents: ‘…need to assess current practice. Determine the
factors that influenced decisions in the setting. What the
provider attitudes are, the way things are organized or-
ganisational/infrastructure issues. What service models
and systems can be used - framework for understanding?
Support for specific arrangements and links to other pro-
grams, business arrangements, workforce funding. These
feasibility issues were researched so decisions could be
made about how to scale up the intervention’ (R).
Scaling up processes that do not consider this infor-
mation were seen by many respondents across occupa-
tion groupings as sub-optimal and more likely to meet
system resistance, and less likely to be sustained in the
longer term.
Different roles of policy makers, practitioners, and
researchers
Respondents across the sample perceived that policy
makers, practitioners/service managers, and researchers
had different but complementary roles to play in the
process of scaling up population health interventions.
Role of researchers Researchers played an important
role in bringing evidence to the attention of opinion
leaders and decision makers, by providing independent
expert opinion and by advocating for particular inter-
ventions or issues. ‘I think they have been particularly
critical in my experience because they can be that expert
independent voice that is needed sometimes that you can
roll out. Basically, a face behind the paper or someone
that can actually put a voice to a paper in front of a
power broker or someone that holds power’ (P/SM). It
was clear that researcher-generated information contrib-
uted to the way policy makers and practitioners thought
about an issue.
Some researchers stated that they participated in dis-
cussions with policy makers about ‘how to’ implement,
while others typically confine their advice to ‘what’ to
implement. It was suggested that there were limited re-
wards for researchers to participate in scaling up
decision-making processes, as one respondent noted: ‘…
because I come originally from a practice background I
am willing to kind of engage in broader discussions but I
think a number of researchers would think that this is
not their job’ (R).Policy makers also noted that there were certain re-
searchers who were well connected with the policy con-
text and were willing to assist in scaling up decision
processes: ‘There’s the researchers that keep their hand in,
they’re the go-to people, the people I can pick up the
phone to. “I’ve got this issue with this, have you got any
evidence around this, what’s your feeling, have you done
some research in this area” and they understood the con-
text that I was talking about because we had worked to-
gether because I knew they were working in the same field,
we all kind of understood each other and I knew what
they were doing and I knew their strengths and capacities.
Those were the go-to people’ (PM).
It was noted by a number of policy makers and practi-
tioners that there was little evaluation conducted by re-
searchers on scaled up interventions: ‘Well, my
experience with researchers is that they never do research
which is about scaling up. Research that’s about scaling
up is probably less attractive to them than research that
either proves something is effective or not…’ (PM).
However, it was suggested by other respondents that
there was scope for researchers to be engaged in on-
going evaluation for scaled up interventions: ‘…providing
the capacity for ongoing evaluation, which may be part
of the plan that the policy makers come up with’ (R).
This opportunity may be particularly salient where prac-
titioners had dual roles as implementers and researchers.
In this regard it was suggested that researchers could en-
sure that intervention evaluations were being imple-
mented with some rigor.
Role of policy makers Policy makers play important
roles in determining priorities, securing resources, and
solidifying leadership and stakeholder support for action.
They make decisions about what to implement and how
to do it based on a variety of factors including the avail-
able evidence. Policy makers may also be involved in
directing the implementation of interventions. As a re-
searcher observed: ‘There are the political factors that
they [policy makers] have to be aware of, in terms of
what the political consequences may be of a program be-
ing rolled out more broadly or continued, to elected the
person at the top of the tree. There are probably internal
political factors that have also got to pay attention to, in
terms of their organisation and support for an area of
work, what the consequences might be for continuing to
scale or deliver a program. They are very dependent on
partnerships and therefore they have got to think about
what the consequences are for the important partnerships
of scaling up’ (R).
Role of practitioners/service managers Practitioners/
service managers in this study described a similar role to
policy makers, but on a local level, as they sought
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had a particularly important role in building the rela-
tionships, systems, processes, and infrastructure that
support the scaling up of population health interventions
into practice. As one service manager put it: ‘So I guess I
lead the process, as the service director so I initiated
some of the earlier discussions, seeking feedback from key
stakeholders and gaining that leadership support and de-
veloping those relationships to actually support the
process and then basically I developed the briefs, etc. to
get it into the level. I had those high level decision meet-
ings, etc.’ (P/SM).
Drivers and incentives for different groups Re-
searchers, policy makers, and practitioners were ob-
served to have different needs, interests, and values
systems that impact on scaling up processes: As a policy
maker observed: ‘Policy makers were trying to find the
best range of tools to improve population health…’ (PM).
It appeared that practitioners/service managers were
driven by similar motivations as policy makers, but had
a greater focus on meeting local community and stake-
holder needs in scaling up processes. A practitioner ob-
served that researchers often have a different motivation
for involvement in scaling up processes: ‘The drivers are
attracting funding and publishing papers not what the
research leads to in a practical sense. I don’t know how
often researchers think about how soon their research is
going to be used or if in fact, it will be used’ (P/SM). This
observation was confirmed by a researcher who said: ‘As
a researcher, we’re not rewarded for it in any way really.
So that’s another factor because everything we’re
rewarded on is just the old metrics and there’s no money
in any grant to do it…’ (R).
Discussion
This is the first study to provide an analysis of how deci-
sions to scale up population health interventions have
actually occurred across a range of projects in developed
country contexts. The study illustrates that decisions to
scale up interventions are typically subject to iterative
policy or practice-based decision-making processes, fre-
quently involving engagement with internal and external
stakeholders. Policy makers generally lead these pro-
cesses, but are subject to decisions by fund holders and
political leaders, who must be convinced of the relevant
merits of action before any action can proceed; a theme
that is consistent with the global health literature
[12,22].
This study’s findings indicate that policy makers, prac-
titioners, and researchers have different but complemen-
tary roles to play in scaling population health
interventions. Consistent with observations of health pol-
icy processes in previous research [16,17,23], respondentsin this study reported that policy makers played a lead
role in shaping priorities, securing resources and solidify-
ing political and broader stakeholders support for large-
scale action [16,17]. Respondents also noted that policy
makers generally made decisions about how to imple-
ment scaling up processes based on a variety of factors,
including the available evidence. As Brownson et al. [16]
observed in the United States, even in the light of sound
scientific data, ideas are sometimes not ready for policy
action, due to lack of public support or competing
interests.
Practitioners/service managers in this study appeared
to perform similar stakeholder management functions to
policy makers, but on a local level. Practitioners de-
scribed being at the ‘coal face’ of many scaling up pro-
cesses, having a proximal role in facilitating practice
change through stakeholder engagement, partnership
building, and service development, and this contribution
to scaling up may sometimes precede larger scale up,
through testing of promising interventions on a local
level prior to further expansion.
While researchers provided information and advice to
decision makers based on their assessments of the avail-
able evidence or the findings of their research, their
greatest contribution to decisions about whether to and
how to scale up interventions, was their influence on the
way decision makers thought about issues, often commu-
nicated through their ongoing links with policy makers.
As Brownson et al. [16] suggest, to achieve influence, re-
searchers need to be aware of policymakers’ concerns
and windows of opportunity to influence policy and prac-
tice, through active involvement and interchange of ideas.
While there are legitimate reasons for researchers to
maintain some level of separation from policymaking and
implementation [16], population health research will
have the greatest impact when its production and appli-
cation are viewed as a shared responsibility between re-
searchers and decision makers [16,24].
Co-production of research between researchers and
end users of research such as policy makers and practi-
tioners involves a different way of working in all parts of
the research process [25], particularly when scaling up
population health interventions. This process ideally in-
volves end user involvement from the inception of re-
search, starting with shaping of research questions,
jointly making decisions on methodology, involvement
in data collection, and tools development, and ends with
the interpretation and dissemination of findings [25].
There is some evidence that, when this occurs, research
findings are more likely to be relevant to end users and
more likely to be used in policy and practice [24]. Co-
production of research requires effective communication
and exchange between researchers, policy makers, and
practitioners. Collaborative mechanisms that facilitate
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search centres [26], collaborative research grants [27],
communities of practice [24], and the use of knowledge
brokers [28].
An important observation by respondents in this study,
again consistent with previous research [3,16,17,29], was
that researchers and policy makers/practitioners have dif-
ferent needs, value systems, and incentives. Effective, effi-
cient, and timely implementation of interventions in a
fashion that is sensitive to key stakeholders’ interests and
political recognition were primary drivers for policy
makers and practitioners [16,23]. While for researchers,
support for scaling up of evidence-based interventions
may not be particularly important, as research funding
and publications were key drivers. Core performance
metrics of individual researchers and research groups are
usually based on the number of publications, grants,
postgraduate research students, and the amount of com-
petitive research funding [29].
Encouragingly, interviews confirmed that evidence in
many forms, including research evidence, was important
to underpin many decisions related to scaling up popula-
tion health interventions. Respondents’ descriptions of
how evidence informed scaling up processes, that is, re-
search being only one of many influences on decision
making, appear to echo the use of research evidence in
broader policy making processes previously described in
the literature [17,30-33].
An interesting observation was that locally-generated
research evidence was highly valued by policy makers
and practitioners as it was perceived to be contextually
relevant and more likely to translate into practice. Local
evidence of efficacy or evidence from local pilots or repli-
cation studies was thought to be particularly persuasive.
However, it is important to note that policy makers and
practitioners in this study described using a ‘body of evi-
dence’, rather than any single research study, as the em-
pirical basis for scaling up an intervention. In most cases,
decision makers noted that there were large gaps in the
available evidence. They often described the need to
search the grey literature and other sources of informa-
tion, such as parallel evidence from other settings, and
rely on practitioner knowledge and expert advice to fill in
these gaps. Echoing these findings, recent interviews with
38 Australia policy makers conducted by Campbell et al.
[34] found that the most common reason for not using
research in policy was the absence of appropriate and/or
relevant research. The study found that while informa-
tion about the large scale implementation of programs is
rarely published, scaling up is a frequent real world oc-
currence, often relying on imperfect evidence [6]. There
remains a paucity of policy and practice relevant forms of
evidence, particularly intervention research with detailed
information on costs and implementation issues in thepublished literature [3,5], or in local settings. An increas-
ing number of policymakers, research funders, and re-
searchers argue that there is an urgent need for high-
quality studies assessing mechanisms by which more
widespread intervention adoption and reach can be
achieved [35-37].
The costs of scaling up interventions are fundamental
to decisions about public health program implementation
[38,39]. Costing of an intervention identifies whether the
various arms of a program are receiving money as was
intended in the original plan and underpins any subse-
quent economic evaluation [40]. Despite its value, this in-
formation is generally absent from research reports and
in particular published intervention studies [6,41]. Given
the importance of economic data to informing scaling up
processes [6], the field should be encouraged to collect
and publish data on intervention costs and, where feas-
ible, cost effectiveness of interventions. Encouragingly,
there are a number of recent international efforts aimed
at facilitating more transparent reporting of intervention
effectiveness and associated costs [42], namely, the Con-
solidated Standards of Reporting Trials (CONSORT)
statement [43] and the Transparent Reporting of Evalua-
tions with Non-randomized Designs (TREND) Statement
[44]. These statements require authors of reports and
journal articles to follow checklists that indicate the type
of information required for research consumers to more
readily use and interpret study findings. Although they
have been established to improve the reporting of re-
search, they also provide researchers with a framework
by which to design the primary research itself [42].
Respondents across occupational groupings in the sam-
ple noted the tension between program fidelity, that is
the extent to which the implementation of the interven-
tion is consistent with intervention protocols previously
found to be effective [45] and the counter-acting pressure
of adaptation, the adjustment of an intervention for dif-
ferent target populations, localities, and organizational
factors [46]. Implementing at scale often requires sub-
stantial simplification of the original model, since the re-
sources necessary for intensive implementation of the
intervention at scale are often not available in real world
settings [8,11,12]. Attaining the right balance that fits the
context and circumstances, but yet retains the effective
ingredients, is vital to the success of scaling up efforts
[6,46,47]. It is important to continue to monitor inter-
vention effectiveness when interventions are simplified
and/or adapted as part of scaling up processes [6,14].
Overall, this study confirms that a key challenge for
the field of population health is to facilitate the timely
provision of policy and practice relevant research evi-
dence into scaling up decision processes. There is oppor-
tunity for more co-production of research that directly
informs efforts to scale up population health action. This
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and journals supporting the generation and publication
of such applied research.
The study findings are based on the substantial experi-
ence of senior policy makers, practitioners, and researchers,
and provide a sound empirical basis for understanding
the process of scaling up population health action in real
world developed country contexts. This study also builds
on the previous scalability research [6] by providing add-
itional rigorous scrutiny and in-depth commentary,
which confirmed how a range of considerations related
to the appropriateness of an intervention for scaling up,
are actually taken into account.
In summary, to be appropriate for scaling up, population
health interventions generally required evidence of effect-
iveness, had the potential for substantially expanded reach
and system adoption, had evidence showing that they were
acceptable to the target groups and settings, and could be
delivered at an acceptable and sustainable cost.
Limitations and further research Though this is the
first study to comprehensively examine how scaling up
decision-making processes occur in the real world across
a range of projects and settings, it did not examine the
appropriateness of particular policies or programs for
scaling up or otherwise. This study engaged a small num-
ber of expert participants, mainly from Australia, though
it is important to note that a number of respondents
were from Asia, Europe, and the United States and were
recognized as international experts in their respective
fields of expertise. While a larger sample or different set
of respondents may have generated some differing views,
the consistency, rigor, and detail of responses to the in-
terviews, as well as the substantial experience of the ex-
perts lend confidence to the results. The considered
approach taken in respondent selection, high response
rate, and strong contributions from all respondents also
add weight to the validity of the findings. There is, how-
ever, merit in determining if the findings identified
amongst this select sample of experts can be replicated
with a larger and more representative sample of policy
makers, practitioners, and researchers.
Conclusions
In order to achieve population-wide health improve-
ments, population health interventions that have been
found to be efficacious in research should be considered
for widespread implementation. A better understanding
of how decisions to scale up interventions are made in
practice, the role of evidence, and the respective roles of
policy makers, practitioners, and researchers have played
in such processes can inform future intervention research
design, intervention development, and scaling up deci-
sions more broadly.At least part of the reason for the uneven dissemin-
ation of intervention research findings into population
health practice appears to be lack of information rele-
vant to the needs of decision makers when they are
managing scaling up processes. The field is encouraged
to address key evidence gaps to better inform scaling up
processes, particularly publishing more intervention re-
search that provides data on the effectiveness, reach, and
costs of operating at scale as well as key service delivery
issues including acceptability and fit of interventions and
delivery models with the local context. Addressing these
evidence gaps would advance the relevance and ultim-
ately usability of research for policymakers and practi-
tioners charged with scaling up population health action.
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